Paragon 28 provides forefoot, midfoot and hindfoot plates, screws, staples and allograft bone systems for use in foot and ankle surgery.
Paragon 28 has raised $150.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in November 2023.
Paragon 28's investors include MVM Life Science Partners, Ares Capital, Piper Jaffray Merchant Banking.
Paragon 28 is headquartered in Englewood, United States.
Paragon 28 provides forefoot, midfoot and hindfoot plates, screws, staples and allograft bone systems for use in foot and ankle surgery.
Paragon 28 is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paragon 28 — Funding & Investors." VCBacked, November 7, 2023, https://www.vcbacked.co/company/paragon-28. Accessed August 14, 2026.
VCBacked. (2023). Paragon 28 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/paragon-28
{{cite web |title=Paragon 28 — Funding & Investors |url=https://www.vcbacked.co/company/paragon-28 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated